Nitto Denko Avecia has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services (Irvine) and Avrio Biopharmaceuticals (Avrio).
Marlborough medical device manufacturer Boston Scientific announced on Friday it was moving forward on a $210-million acquisition of EndoChoice Holdings, Inc. in Georgia.
Marlborough-based CardioFocus announced Tuesday that its system for treating patients with irregular heart beats was used successfully in its first commercial U.S. procedure.
On the back of major business wins, such as GE Healthcare Life Sciences and Quest Diagnostics, Marlborough now has its sights set on smaller businesses and downtown.
A six-week trial by Sunovion Pharmaceuticals Inc. found the drug candidate dasotraline was generally well-tolerated and demonstrated a statistically significant difference in children with ADHD.